As the enforcement of abuse of dominance cases across the globe continues to gather momentum across high-stakes sectors like life sciences, pharma, and AI, our panellists will discuss and share predictions and perspectives on the most important developments and issues in their regions. With regulators scrutinising everything from drug affordability to digital interoperability, how are traditional antitrust theories of dominance evolving? Are new AI product integrations inherently exclusionary? How should digital platforms navigate conflicting regulatory demands across jurisdictions? How can global pharma companies balance diverging enforcement priorities regarding pricing and patent strategies?